Evidence map›Paper›PMID 34161602›Full record

Trial reportCancer2021

A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity.

Justin C Brown, David B Sarwer, Andrea B Troxel, Kathleen Sturgeon, Angela M DeMichele, Crystal S Denlinger, Kathryn H Schmitz

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Physical activity and pain in people with cancer: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Justin C BrownDivision of Population and Public Health Sciences, Department of Cancer Energetics, Pennington Biomedical Research Center, Baton Rouge, Louisiana.ORCID 0000-0001-7540-4913
David B SarwerDepartment of Social and Behavioral Sciences, Temple University College of Public Health, Philadelphia, Pennsylvania.
Andrea B TroxelDivision of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York.
Kathleen SturgeonDepartment of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.
Angela M DeMicheleDivision of Medical Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Crystal S DenlingerDepartment of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Kathryn H SchmitzDepartment of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania.

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Phenotypic Diversity in COVID-19UL1TR001878 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2016 to 2025
$102.4M
Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
Institutional Clinical and Translational Science AwardUL1TR000003 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2015
$38.9M
Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Sujoy Ghosh · 2005 to 2026
$26.5M
The Women In Steady Exercise Research (WISER) SurwVor TrialU54CA155850 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHMITZ, KATHRYN H. · 2011 to 2015
$9.1M
Penn State Institutional Career Development CoreKL2TR002015 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI VAN SCOY, LAUREN JODI · 2016 to 2025
$7.8M
Transdisciplinary Research in Energetics and Cancer (TREC) Training GrantR25CA203650 · NCI · YALE UNIVERSITY · PI IRWIN, MELINDA L · 2016 to 2025
$2.9M
Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric SurgeryR01DK108628 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI SARWER, DAVID B · 2015 to 2019
$2.1M
Inflammation, Physical Activity, and Colon Cancer Recurrence and SurvivalR00CA218603 · NCI · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI BROWN, JUSTIN C · 2019 to 2021
$747k
NCATS NIH HHS KL2 TR002015NCATS NIH HHS UL1 TR000003NCATS NIH HHS UL1 TR001878NCATS NIH HHS UL1 TR002014NCI NIH HHS P30 CA006927NCI NIH HHS P30 CA016520NCI NIH HHS R00 CA218603NCI NIH HHS R25 CA203650NCI NIH HHS U54 CA155850NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK108628NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

backgroundObesity is a chronic, relapsing, and progressive disease; it is associated with poor health-related quality of life (HRQOL) in survivors of breast cancer.

methodsIn this 2 × 2 factorial trial, 351 survivors of breast cancer with overweight or obesity were randomized to 1 of 4 treatment groups for 52 weeks: control, exercise alone, diet alone, or exercise plus diet. HRQOL end points were measured at baseline and at week 52 using the 36-Item Medical Outcomes Survey-Short Form (SF-36). Repeated measures analysis of covariance quantified the estimated treatment difference (ETD).

resultsAt baseline, participants had a mean (SD) age of 59.4 years (8.7), body mass index of 34.0 kg/m

conclusionIn survivors of breast cancer with overweight or obesity, exercise plus diet improved select HRQOL end points at week 52.

Indexed as

Breast NeoplasmsQuality of LifeDietFemaleHumansMiddle AgedNeoplasm Recurrence, LocalObesityOverweightSurvivorsexerciseobesityrandomized trialsurvivorshipweight loss

Identifiers

PMID34161602
PMCPMC8478822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.